Nexavar Tablet, Film Coated
Product Images NDC 50419-488

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nexavar (NDC 50419-488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7c4c29f2 1bbf 4eb3 8685 A44154d1c198 00

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Fig 1 (Image 02)

FDA Label Image

Fig 2 (Image 03)

This text is describing the progression-free survival probability and median survival time in days for patients who received NEXAVAR (N=384) and Placebo (N=385). It also includes Hazard Ratio and p-value. The text also presents a graph with the survival probability over time.*

FDA Label Image

Fig 3 (Image 04)

The text shows results of a clinical trial evaluating the efficacy of NEXAVAR compared to a placebo. The study included 207 patients in the NEXAVAR group and 210 patients in the Placebo group. The text provides a graph showing the proportion of progression-free survival over time for each treatment group. It also includes a table showing the number of patients at risk in each group at various time points during the study.*

FDA Label Image

Label

This is a product description for Nexavar tablets manufactured by Bayer HealthCare Pharmaceuticals. Each tablet contains 200mg sorafenib and there are 120 tablets in a bottle. The NDC number is 5041948356 and the batch number and expiry date are not available due to incomplete reading.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.